Putting Your Skills and Passion to Work at BMS: RayzeBio in San Diego and Indianapolis
When BMS acquired RayzeBio in 2024, our product pipeline expanded to include radiopharmaceutical therapies (RPTs), an innovative approach to cancer treatment that aims to deliver radioisotopes directly to cancer cells while seeking to spare healthy cells and minimizing side effects. Having RPTs in our portfolio also expanded possibilities for professionals with experience in radiopharmaceuticals or small molecules to join RayzeBio’s fast-growing teams at its headquarters in San Diego and new manufacturing site in Indianapolis. This opportunity to be part of our talented, high-achieving teams united by a common mission led Christopher (Chris) Nikodem, Senior Director, Engineering to relocate from the East Coast to Indianapolis. Learn about the career path that […]
Putting Your Skills and Passion to Work at BMS: RayzeBio in San Diego and Indianapolis Read More »
When BMS acquired RayzeBio in 2024, our product pipeline expanded to include radiopharmaceutical therapies (RPTs), an innovative approach to cancer treatment that aims to deliver radioisotopes directly to cancer cells while seeking to spare healthy cells and minimizing side effects. Having RPTs in our portfolio also expanded possibilities for professionals with experience in radiopharmaceuticals or small molecules to join RayzeBio’s fast-growing teams at its headquarters in San Diego and new manufacturing site in Indianapolis. This opportunity to be part of our talented, high-achieving teams united by a common mission led Christopher (Chris) Nikodem, Senior Director, Engineering to relocate from the East Coast to Indianapolis. Learn about the career path that












